Moneycontrol
HomeNewsIndiaCoronavirus pandemic | First patient to receive plasma therapy in Uttar Pradesh dies of heart attack
Trending Topics

Coronavirus pandemic | First patient to receive plasma therapy in Uttar Pradesh dies of heart attack

Since he had high blood pressure and diabetes, he was under the continuous observation of doctors in the isolation ward, KGMU Vice Chancellor Bhatt said.

May 09, 2020 / 19:43 IST
Story continues below Advertisement

The first patient to receive plasma therapy as an experimental treatment for coronavirus infection in Uttar Pradesh died following a heart attack on Saturday. The patient, a 58-year-old doctor, was admitted at the King George's Medical University (KGMU) here.

The doctor, who was on ventilator since the last 14 days, died on Saturday evening following heart attack, KGMU Vice Chancellor M L B Bhatt said.

Story continues below Advertisement

Since he had high blood pressure and diabetes, he was under the continuous observation of doctors in the isolation ward, Bhatt said.

Coronavirus India LIVE News Updates

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show